Microbiology & Infectious Diseases

Early gut microbiota changes may predict diabetes, recurrence, and mortality after acute pancreatitis, offering new tools for long-term risk assessment.

Universal infant nirsevimab prophylaxis significantly reduced RSV-related hospitalisations and outpatient visits across two seasons in Spain.

Rising pTau-181 after COVID-19 correlates with neurological post-acute sequelae, offering clinicians potential prognostic insight.

New guidelines update ART choices, endorse long-acting injectables, refine infant feeding advice, and prioritise shorter TB preventive regimens.

Expansion of antiretroviral therapy in Uganda sharply reduced orphanhood incidence, especially among adolescents, but substantial risk persists.

A recent perspective highlights challenges in translating human microbiome research into consistent clinical benefits and precision interventions.

Pooled trial data show gepotidacin provides early, meaningful symptom relief comparable to nitrofurantoin in uncomplicated urinary tract infection.

Children facing economic instability and poor social support in the USA have higher odds of long COVID, highlighting the role of social determinants in child health.